AUSTIN, Texas--(BUSINESS WIRE)--Over the past several days, Introgen Therapeutics, Inc. (NASDAQ: INGN) was the subject of at least two mentions in thestreet.com, a web-based publication and an internet web log, or blog, that referenced thestreet.com article. Introgen denounces the publications as false and misleading.
